Gulf Resources Announces Conference Call to Discuss Third Quarter 2016 Results
Nov 11, 2016 13:30 pm UTC| Business
SHOUGUANG, China, Nov. 11, 2016 -- Gulf Resources, Inc. (Nasdaq:GURE) ("Gulf Resources" or the "Company"), a leading manufacturer of bromine, crude salt and specialty chemical products in China, today announced that the...
Wowo Limited to Hold Annual General Meeting on December 15, 2016
Nov 11, 2016 13:30 pm UTC| Business
SHANGHAI, China, Nov. 11, 2016 -- Wowo Limited (NASDAQ:JMU) (“JM Wowo” or the “Company”), a leading B2B online e-commerce platform that provides integrated services to suppliers and customers in the foodservice industry...
Points International to Present at the Three Part Advisors’ Southwest IDEAS Investor Conference
Nov 11, 2016 13:30 pm UTC| Business
TORONTO, Nov. 11, 2016 -- Points (TSX:PTS) (Nasdaq:PCOM), the global leader in powering loyalty commerce, today announced that its President, Christopher Barnard and Chief Financial Officer, Michael D’Amico will present...
Nov 11, 2016 13:30 pm UTC| Business
CHICAGO, Nov. 11, 2016 -- The Female Health Company/Veru Healthcare (NASDAQ:FHCO) today announced that it has accepted an invitation from the U.S. Food and Drug Administration (FDA) to present at the Meeting of the...
Nov 11, 2016 13:30 pm UTC| Business
NOVATO, Calif., Nov. 11, 2016 -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced that is has...
SC16 Uses ADVA Optical Networking 100G Technology to Support SCinet
Nov 11, 2016 13:12 pm UTC| Business
Compact, Low-Power Transport Solution Contributes to Unique Research and Education Network SALT LAKE CITY, Nov. 11, 2016 -- ADVA Optical Networking announced today that the SC16 Conference is using its 100Gbit/s core...
Argos Therapeutics to Participate in Upcoming Investor Conferences
Nov 11, 2016 13:00 pm UTC| Business
DURHAM, N.C., Nov. 11, 2016 -- Argos Therapeutics Inc. (Nasdaq:ARGS) (“Argos”), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis®...